Date: 2016-11-29
Type of information: Production agreement
Compound: undisclosed product
Company: AMRI (USA - NY) Shire (UK - USA)
Therapeutic area: undisclosed
Type agreement: production manufacturing
Action mechanism:
Disease:
Details: * On November 29, 2016, AMRI announced that it has entered into a multi-year supply agreement for an undisclosed product with Shire US Manufacturing, which product has been in AMRI's portfolio through the required stages of development. The terms of the agreement are confidential. This is the second such multi-year agreement between AMRI and Shire, as AMRI has also been supplying a key neuroscience product to Shire.
Financial terms:
Latest news:
